Total raised
$6.0M
Last: Series A 2024-12
Stage
Series A
Founded
2021
Headcount
25
HQ
Netanya
Sector
Health Tech & Life Sciences
About
CalmiGo is a drug-free device designed to provide immediate relief during moments of anxiety and distress by regulating the user’s breathing patterns and senses, thereby alleviating symptoms on the spot.
CalmiGo uses three proven techniques to decrease stress hormone levels by enabling the body to quiet the stressful sympathetic nervous system while activating the calming parasympathetic nervous system through the use of personalized breathing regulation, multisensory stimulation, and soothing scents.
CalmiGo was developed by Dendro Technologies Inc.
Funding history · 2 rounds · $6.0M total
2024-12
Series A
Undisclosed
2021-03
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Semiconductors & ElectronicsDigital Signal ProcessorSensingVibration
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2C
Highlights
1 Patents
Tags
mental-healthmedical-devicesneuro-stimulationneurology